
June 4, 2026
Seven-year collaboration puts WellSpan at the forefront of diagnostics and imaging in community health through a groundbreaking research and innovation strategy aimed at shaping the future of care delivery
Amsterdam and YORK, Pa. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and WellSpan Health, the leading health care system in Central Pennsylvania and Northern Maryland, today announced a landmark seven-year strategic alliance that establishes a new research and innovation collaboration and brings new advanced imaging and diagnostics technology products and platforms to patients across the region. The alliance is the latest addition to WellSpan’s growing innovation ecosystem, positioning the system as a national leader in the application of artificial intelligence and technology in health care.

"As WellSpan has grown in clinical capability, so has our responsibility to be more intentional about how we plan, deploy and support the life-saving technology our teams and patients rely on," said Roxanna Gapstur, Ph.D., R.N., WellSpan president and CEO. "This collaboration gives us that foundation, bringing consistency and coordination across our entire system, advancing digital and AI-enabled care and building a leading research and co-development platform that will transform the future of health care. Community health systems like WellSpan are where most Americans receive care, and we are proving they belong at the center of health care innovation."
The collaboration includes a research agreement and joint innovation strategy, the first of its kind between Philips and a U.S. community health system, which will focus on validating the performance of new tools and technology. Research is expected to examine how AI and digital tools are improving throughput, cost and workflow efficiency, aimed at advancing WellSpan's commitment to reclaim more than half a million hours of workforce time annually.
In addition, the innovation component of this relationship will allow WellSpan, together with Philips Research, to co-develop net-new products and features that advance care delivery. This work will draw on Philips' R&D pipeline to design and develop future generations of health care technology, with WellSpan serving as both a proving ground and a co-creator.
A long-term commercial agreement establishes Philips as WellSpan’s preferred vendor across all applicable imaging modalities (CT, MR, digital X-ray, ultrasound, and image-guided therapy). The agreement covers all 12 WellSpan hospitals, as well as its diagnostic imaging centers and ambulatory surgery centers, ensuring a consistent experience for patients wherever they need care. A defining feature of the commercial agreement is its structured approach to technology lifecycle management: WellSpan and Philips will align equipment, service, training and upgrade planning under a single coordinated framework, enabling more consistent imaging availability across sites, reducing gaps in access for patients and laying the foundation for continued innovation.
“This collaboration builds on a long-standing relationship between Philips and WellSpan, and it also marks an important evolution in how we work together,” said Roy Jakobs, CEO, Royal Philips. “By combining our health technology leadership with WellSpan’s clinical expertise and research focus, we’re creating a long-term alliance designed to drive measurable improvements in patient care quality, operational performance and innovation. Together, we’re establishing a scalable, AI-driven, platform-based approach that supports clinicians today while shaping how care is delivered in the future.”
*The opinions and clinical experiences presented herein are specific to the featured topic(s) and are not linked to any specific patient and are for information purposes only. The medical experience(s) derived from specified topic(s) may not be predictive of all patients. Individual results may vary depending on a variety of patient-specific attributes and related factors. Nothing in this news announcement is intended to provide specific medical advice or to take the place of written law or regulations.
Contact:
Avi Dines
Philips North America
Tel: +1-781-690-3814
Email: avi.dines@philips.com
Jayme Maniatis
Philips Global External Relations
Tel.: +1 617 894 8368
E-mail: jayme.maniatis@philips.com
Contact:
Ryan Coyle
WellSpan Health
Tel: +1-717-851-3151
Email: RCoyle@WellSpan.org
About WellSpan Health
WellSpan Health’s vision is to reimagine healthcare through the delivery of comprehensive, equitable health and wellness solutions throughout our continuum of care. As an integrated delivery system focused on leading in value-based care, we encompass more than 2,700 employed providers, more than 250 locations, 12 award-winning hospitals, home care and a behavioral health organization serving Central Pennsylvania and Northern Maryland. Our high-performing Medicare Accountable Care Organization (ACO) is the region’s largest and one of the best in the nation. With a team 23,000 strong, WellSpan experts provide a range of services, from wellness and employer services solutions to advanced care for complex medical and behavioral conditions. Our clinically integrated network of 3,000 aligned physicians and advanced practice providers is dedicated to providing the highest quality and safety, inspiring our patients and communities to be their healthiest.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of approximately EUR 18 billion and employs approximately 64,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachment
-
云顶新耀与天广实达成倍捷欣(R)商业化授权许可协议 深化亚太创新药市场布局来源 Everest Medicines Limited2026-06-04
-
Laserfiche登陆AWS Marketplace,为企业带来智能内容管理智能内容管理领域的领先SaaS供应商Laserfiche已与AWS达成合作,通过AWS Marketplace提供Laserfiche服务。此次合作使AWS客户能够无缝采购Laserfiche的文档管理平台,2026-06-04
-
Kinaxis推出前置部署工程服务,助力企业将决策转化为实际成果供应链规划与协同领域的全球领导者Kinaxis® Inc. (TSX:KXS)今日推出“前置部署工程”(Forward Deployed Engineering, FDE)。这种全新的合作模式旨在帮助企业将A2026-06-04
-
慧辰股份发布《2026年中国具身智能产业系列研究报告之人形机器人篇》具身智能首次写入政府工作报告,与生物制造、量子科技、6G并列成为国家重点培育的未来产业,而人形机器人作为具身智能最核心、复杂度最高的通用载体,正从样机演示2026-06-04
-
Airgain借助AT&T打造的FirstNet扩展其公共安全与公用事业连接产品组合先进无线连接解决方案的领先供应商Airgain , Inc. (NASDAQ: AIRG)今日宣布,将通过由AT&T打造的美国公共安全网络FirstNet®进一步扩展其关键任务连接产品组合,为全2026-06-04
-
AMD股价暴跌17%创近9年之最,苏姿丰紧急回应:AI增速远超想象
-
Ledger 中国销售渠道说明:广州馨潇贸易有限公司官方直营渠道公示
-
江苏省脑机接口产业联盟在宁成立,麦澜德分享前沿成果
-
艾芬达入选国家知识产权强国建设示范创建对象:二十载长期主义,兑现每一份用户价值
-
Esentia宣布成功完成2033年到期的6.125%优先票据和2038年到期的6.500%优先票据的定价
-
中荷人寿北京分公司成功举办中荷创享家品牌发布暨协同发展启航仪式
-
华为系具身智能公司具脑磐石完成新一轮融资:对标JEPA,押注类脑智能的认知世界模型
-
北京暑假补习班有哪些?家长首推一对一权威机构金博升学
-
慧启赣疆 聚势共赢丨慧友酒店集团江西品鉴会书写区域文旅融合新篇
-
电影《一秒》定档:2026年,活在这一秒
